Dynamics of papillomavirus in vivo disease formation & susceptibility to high-level disinfection-Implications for transmission in clinical settings.

[1]  A. Waxman,et al.  Infectious titres of human papillomaviruses (HPVs) in patient lesions, methodological considerations in evaluating HPV infectivity and implications for the efficacy of high-level disinfectants , 2021, EBioMedicine.

[2]  N. Thilly,et al.  Human papillomavirus vaccination coverage, policies, and practical implementation across Europe. , 2019, Vaccine.

[3]  M. Ozbun,et al.  Extracellular events impacting human papillomavirus infections: Epithelial wounding to cell signaling involved in virus entry , 2019, Papillomavirus research.

[4]  S. Brendle,et al.  Papillomavirus can be transmitted through the blood and produce infections in 1 blood recipients : Evidence from two animal models 2 3 , 2019 .

[5]  S. Humiston,et al.  Using the 4 Pillars™ Practice Transformation Program to increase adolescent human papillomavirus, meningococcal, tetanus-diphtheria-pertussis and influenza vaccination. , 2017, Vaccine.

[6]  R. Mahmood,et al.  HPV16 and 18 genome amplification show different E4-dependence, with 16E4 enhancing E1 nuclear accumulation and replicative efficiency via its cell cycle arrest and kinase activation functions , 2017, PLoS pathogens.

[7]  R. Robison,et al.  Susceptibility of HPV16 and 18 to high level disinfectants indicated for semi‐critical ultrasound probes , 2015, Journal of medical virology.

[8]  Albert Y. Chi,et al.  Using the inverse Poisson distribution to calculate multiplicity of infection and viral replication by a high-throughput fluorescent imaging system , 2016, Virologica Sinica.

[9]  K. Egawa,et al.  Human Papillomaviruses; Epithelial Tropisms, and the Development of Neoplasia , 2015, Viruses.

[10]  N. Christensen,et al.  A Novel Pre-Clinical Murine Model to Study the Life Cycle and Progression of Cervical and Anal Papillomavirus Infections , 2015, PloS one.

[11]  W. Quint,et al.  Stratification of HPV-Induced Cervical Pathology using the Virally-Encoded Molecular Marker E4 in Combination with p16 or MCM , 2015, Modern Pathology.

[12]  B. Trus,et al.  Maturation of the Human Papillomavirus 16 Capsid , 2014, mBio.

[13]  M. Ozbun,et al.  Using Organotypic (Raft) Epithelial Tissue Cultures for the Biosynthesis and Isolation of Infectious Human Papillomaviruses , 2014, Current protocols in microbiology.

[14]  R. Robison,et al.  Susceptibility of high-risk human papillomavirus type 16 to clinical disinfectants. , 2014, The Journal of antimicrobial chemotherapy.

[15]  J. Doorbar.  The E4 protein; structure, function and patterns of expression. , 2013, Virology.

[16]  W. Quint,et al.  E4 Antibodies Facilitate Detection and Type-Assignment of Active HPV Infection in Cervical Disease , 2012, PloS one.

[17]  M. Stanley,et al.  Human papillomavirus vaccines--immune responses. , 2012, Vaccine.

[18]  N. Christensen,et al.  Differentiation-Dependent Interpentameric Disulfide Bond Stabilizes Native Human Papillomavirus Type 16 , 2011, PloS one.

[19]  A. Zisman,et al.  Sterility of reusable transrectal ultrasound transducer assemblies for prostate biopsy reprocessed according to food and drug administration guidelines--bacteriologic outcomes in a clinical setup. , 2011, Urology.

[20]  D. Lowy,et al.  Carrageenan Is a Potent Inhibitor of Papillomavirus Infection , 2006, PLoS pathogens.

[21]  M. Yarmush,et al.  Charged polymers modulate retrovirus transduction via membrane charge neutralization and virus aggregation. , 2004, Biophysical journal.

[22]  D. Lowy,et al.  Efficient Intracellular Assembly of Papillomaviral Vectors , 2004, Journal of Virology.

[23]  M. Ozbun,et al.  Infectious human papillomavirus type 31b: purification and infection of an immortalized human keratinocyte cell line. , 2002, The Journal of general virology.

[24]  D. Brown,et al.  Transmission of human papillomavirus type 11 infection by desquamated cornified cells. , 2001, Virology.

[25]  D. Brown,et al.  Association of the human papillomavirus type 11 E1()E4 protein with cornified cell envelopes derived from infected genital epithelium. , 2000, Virology.

[26]  L. Meisner,et al.  Normal growth and differentiation in a spontaneously immortalized near-diploid human keratinocyte cell line, NIKS. , 2000, The Journal of investigative dermatology.

[27]  E. Flores,et al.  Establishment of the human papillomavirus type 16 (HPV-16) life cycle in an immortalized human foreskin keratinocyte cell line. , 1999, Virology.

[28]  J. Harris,et al.  Papillomavirus Assembly Requires Trimerization of the Major Capsid Protein by Disulfides between Two Highly Conserved Cysteines , 1998, Journal of Virology.

[29]  D. Lowy,et al.  Papillomavirus is resistant to desiccation. , 1997, The Journal of infectious diseases.

[30]  M. Monga,et al.  Ineffectiveness of Latex Condoms in Preventing Contamination of the Transvaginal Ultrasound Transducer Head , 1997, Southern medical journal.

[31]  J. Dillner,et al.  Surface conformational and linear epitopes on HPV-16 and HPV-18 L1 virus-like particles as defined by monoclonal antibodies. , 1996, Virology.

[32]  V. Rooks,et al.  Comparison of Probe Sheaths for Endovaginal Sonography , 1996, Obstetrics and gynecology.

[33]  Lionel A. Carreira,et al.  A RIGOROUS TEST FOR SPARC'S CHEMICAL REACTIVITY MODELS : ESTIMATION OF MORE THAN 4300 IONIZATION PKAS , 1995 .